Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v13-FR Version v2-FR
Language French French
Date Updated 2017-11-07 2017-03-11
Drug Identification Number 02369699 02369699
Brand name APO-TOLTERODINE APO-TOLTERODINE
Common or Proper name TOLTERODINE TOLTERODINE
Company Name APOTEX INC APOTEX INC
Ingredients TOLTERODINE TARTRATE TOLTERODINE TARTRATE
Strength(s) 2MG 2MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL
Packaging size 100 BTL 100 BTL
ATC code G04BD G04BD
ATC description OTHER UROLOGICALS, INCL ANTISPASMODICS OTHER UROLOGICALS, INCL ANTISPASMODICS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2017-02-08 2017-02-08
Estimated end date 2017-11-24 Unknown
Actual end date 2017-11-06
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments